These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25234714)

  • 21. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
    Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B
    Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
    Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
    Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of microRNA-224 confers a poor prognosis in glioma patients.
    Lu S; Wang S; Geng S; Ma S; Liang Z; Jiao B
    Clin Transl Oncol; 2013 Jul; 15(7):569-74. PubMed ID: 23263909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
    Chen T; Wang XY; Li C; Xu SJ
    Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-650 expression in glioma is associated with prognosis of patients.
    Sun B; Pu B; Chu D; Chu X; Li W; Wei D
    J Neurooncol; 2013 Dec; 115(3):375-80. PubMed ID: 24062138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
    Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
    J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-599 as a potential biomarker for prognosis of glioma.
    Zhu XY; Li GX; Liu ZL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):294-298. PubMed ID: 29424886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of microRNA-134 correlates with malignancy and poor prognosis in human glioma.
    Zhong J; Li B
    J Clin Neurosci; 2015 Mar; 22(3):583-7. PubMed ID: 25564273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of miR-183 expression and its clinical significance in human brain glioma.
    Ye Z; Zhang Z; Wu L; Liu C; Chen Q; Liu J; Wang X; Zhuang Z; Li W; Xu S; Hang C
    Neurol Sci; 2016 Aug; 37(8):1341-7. PubMed ID: 27215622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Potential Prognostic Value of MicroRNA-429 for Human Gliomas.
    Sun X; Li Z; Chen Y
    Ann Clin Lab Sci; 2016; 46(1):44-8. PubMed ID: 26927341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of microRNA-218 and its clinicopathological and prognostic significance in human glioma cases.
    Cheng MW; Wang LL; Hu GY
    Asian Pac J Cancer Prev; 2015; 16(5):1839-43. PubMed ID: 25773834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-182 as a prognostic marker for glioma progression and patient survival.
    Jiang L; Mao P; Song L; Wu J; Huang J; Lin C; Yuan J; Qu L; Cheng SY; Li J
    Am J Pathol; 2010 Jul; 177(1):29-38. PubMed ID: 20472885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
    Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
    Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of microRNA-210 in gliomas of variable cell origin and correlation between increased expression levels and disease progression in astrocytic tumours.
    Lai N; Zhu H; Chen Y; Zhang S; Zhao X; Lin Y
    Folia Neuropathol; 2014; 52(1):79-85. PubMed ID: 24729345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-expression of miR-373 predicts poor prognosis of glioma and could be a potential therapeutic target.
    Jing SY; Jing SQ; Liu LL; Xu LF; Zhang F; Gao JL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2421-2425. PubMed ID: 28617546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance.
    Wang L; Wu L; Wu J
    J Int Med Res; 2016 Oct; 44(5):994-1001. PubMed ID: 27417886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between downexpression of miR-1301 and poor prognosis in patients with glioma.
    Bai QL; Hu CW; Wang XR; Yin GF; Shang JX
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4298-4303. PubMed ID: 29077167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
    Chen XD; Zhu MX; Wang SJ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.